Received Mar 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
had severe fever blisters on his/her lips; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever blister in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 2 days after receiving Shingrix, the patient experienced fever blister (Verbatim: had severe fever blisters on his/her lips). The outcome of the fever blister was not reported. It was unknown if the reporter considered the fever blister to be related to Shingrix. It was unknown if the company considered the fever blister to be related to Shingrix. Additional Information: GSK Receipt Date: 26-FEB-2025 The patient self reported this case for himself/herself. This case was reported by a patient via (shingrix GSK chatbot) interactive digital media. After his/her first shingles shot 2-3 days later he/she had severe fever blisters on his/her lips and was asking was that normal.